Skip to main content

Table 3 Inclusion and exclusion criteria for participants in this study

From: Study protocol to investigate the efficacy of normalisation of Advance Care Planning (ACP) for people with chronic diseases in acute and community settings: a quasi-experimental design

Group

Inclusion criteria

Exclusion criteria

Group 1: People with Chronic Diseases

▪ Patients aged ≥18 years old

â–ª Admitted to the wards/community centres in participating hospitals and community settings,

â–ª Identified in Medical Records as having a chronic health condition(s) (defined within this research project as; Diabetes, Congestive Heart Failure, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease, Hypertension, Chronic Kidney Disease, Cancer, Frailty and Dementia.

â–ª Patients who do not currently have an Advance Care Directive

â–ª Women who are pregnant and the human foetus.

▪ Children and/or young people (< 18 years old).

â–ª People highly dependent on medical care.

â–ª People who are experiencing acute severe physical illness and/or an acute episode of mental illness (a diagnosis of anxiety alone may not exclude participation)

Group 2: Substitute Decision Makers (SDMs)

• ≥18 years old

• Nominated as an SDM by people with chronic diseases at intervention site

• The ability to give valid informed consent

▪ Children and/or young people (<  18 years old).

â–ª People who are experiencing acute severe physical illness and/or an acute episode of mental illness (a diagnosis of anxiety alone may not exclude participation)

Group 3: Admitting Healthcare Professionals (MOs, RNs, &/or SW) at intervention sites (normalisation agents level one, or NA1)

▪ ≥18 years old

â–ª The ability to give valid informed consent

â–ª Working in a professional capacity admitting patients to one of the research units listed, or

â–ª Employed and trained as a NA2 for this research study.

â–ª Not working in one of the research units listed

Group 4: RNs delivering the intervention (referred to as ‘RN ACP Facilitators’) at intervention sites (normalisation agents level two, or NA2).

▪ ≥18 years old

â–ª The ability to give valid informed consent

â–ª Employed and trained as a NA2 for this research study.

â–ª Not employed and trained as a NA2 for this research study